Patent | Date |
---|
Piperidine Derivatives As Modulators Of Chemokine Receptor Ccr5 App 20100010007 - Faull; Alan ;   et al. | 2010-01-14 |
Piperidine derivatives as modulators of chemokine receptor CCR5 Grant 7,615,555 - Faull , et al. November 10, 2 | 2009-11-10 |
Chemical Compounds App 20080200460 - Brown; Dearg ;   et al. | 2008-08-21 |
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) Grant 7,342,020 - Barlaam , et al. March 11, 2 | 2008-03-11 |
Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5 App 20080021038 - Tucker; Howard ;   et al. | 2008-01-24 |
Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5. App 20070259914 - Tucker; Howard | 2007-11-08 |
Treatment of oropharyngeal disorders by application of neuromuscular electrical stimulation Grant 7,280,873 - Freed , et al. October 9, 2 | 2007-10-09 |
Chemical compounds App 20070167442 - Faull; Alan ;   et al. | 2007-07-19 |
Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) App 20070161646 - Tucker; Howard | 2007-07-12 |
Piperidine derivatives as ccr5 receptor modulators App 20070112022 - Brown; Dearg ;   et al. | 2007-05-17 |
Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) Grant 7,192,973 - Tucker March 20, 2 | 2007-03-20 |
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents Grant 7,153,857 - Finlay , et al. December 26, 2 | 2006-12-26 |
Metalloproteinase inhibitor compounds App 20060287338 - Barlaam; Christophe B. ;   et al. | 2006-12-21 |
Metalloproteinase inhibitor compounds Grant 7,122,551 - Barlaam , et al. October 17, 2 | 2006-10-17 |
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20060229313 - Finlay; Raymond ;   et al. | 2006-10-12 |
Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity App 20060205769 - Brown; Dearg ;   et al. | 2006-09-14 |
Novel piperidine derivatives as modulators of chemokine receptor ccr5 App 20060189650 - Cumming; John ;   et al. | 2006-08-24 |
Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors App 20060173041 - Burrows; Jeremy Nicholas ;   et al. | 2006-08-03 |
N-sulfonylpiperidines as metalloproteinase inhibitors (tace) App 20060142336 - Burrows; Jeremy Nicholas ;   et al. | 2006-06-29 |
Method and apparatus for treating oropharyngeal disorders with electrical stimulation Grant 7,039,468 - Freed , et al. May 2, 2 | 2006-05-02 |
Novel piperidine derivaties as modulators of chemokine receptor ccr5 App 20060069120 - Oldfield; John ;   et al. | 2006-03-30 |
Hydantoin derivatives and deren verwendung als tace inhibitoren App 20060063818 - Burrows; Jeremy Nicholas ;   et al. | 2006-03-23 |
Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors App 20060063783 - Burrows; Jeremy Nicholas ;   et al. | 2006-03-23 |
Novel piperidine derivatives as modulators of chemokine receptor ccr5 App 20060052413 - Tucker; Howard | 2006-03-09 |
I-sulphonlyl piperidine derivatives App 20060019994 - Burrows; Jeremy Nicholas ;   et al. | 2006-01-26 |
Sulphonamide derivatives and their use as tace inhibitors App 20050256176 - Burrows, Jeremy Nicholas ;   et al. | 2005-11-17 |
Inhibitors of metalloproteinases Grant 6,916,817 - Tucker July 12, 2 | 2005-07-12 |
Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) App 20050014788 - Cumming, John ;   et al. | 2005-01-20 |
Novel piperidine derivatives as modulators of chemokine receptors App 20040266823 - Cumming, John ;   et al. | 2004-12-30 |
Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) App 20040267016 - Tucker, Howard | 2004-12-30 |
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20040235858 - Tucker, Howard | 2004-11-25 |
Treatment of oropharyngeal disorders by application of neuromuscular electrical stimulation App 20040220645 - Freed, Marcy L. ;   et al. | 2004-11-04 |
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20040220185 - Finlay, Raymond ;   et al. | 2004-11-04 |
Compounds App 20040176386 - Barlaam, Christophe B. ;   et al. | 2004-09-09 |
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists Grant 6,787,562 - Breault , et al. September 7, 2 | 2004-09-07 |
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) App 20040171641 - Barlaam, Bernard C. ;   et al. | 2004-09-02 |
N-4-piperidinyl compounds as ccr5 modulators App 20040110952 - Burrows, Jeremy ;   et al. | 2004-06-10 |
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) Grant 6,734,184 - Barlaam , et al. May 11, 2 | 2004-05-11 |
Compounds Grant 6,734,183 - Barlaam , et al. May 11, 2 | 2004-05-11 |
Method and apparatus for treating oropharyngeal disorders with electrical stimulation App 20040034396 - Freed, Marcy L. ;   et al. | 2004-02-19 |
Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity App 20040006081 - Burrows, Jeremy ;   et al. | 2004-01-08 |
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists App 20030139418 - Breault, Gloria Anne ;   et al. | 2003-07-24 |
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20030139419 - Barlaam, Bernard ;   et al. | 2003-07-24 |
Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp) App 20030100548 - Barlaam, Bernard Christophe ;   et al. | 2003-05-29 |
Method and apparatus for treating oropharyngeal, respiratory and oral motor neuromuscular disorders with electrical stimulation App 20030093128 - Freed, Marcy L. ;   et al. | 2003-05-15 |
Compounds App 20020022628 - Barlaam, Christophe B. ;   et al. | 2002-02-21 |
Method and apparatus for treating oropharyngeal, respiratory and oral motor neuromuscular disorders with electrical stimulation App 20020010495 - Freed, Marcy L. ;   et al. | 2002-01-24 |
Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation Grant 6,198,970 - Freed , et al. March 6, 2 | 2001-03-06 |
Device for treating dysphagia with electrical stimulation Grant 6,104,958 - Freed , et al. August 15, 2 | 2000-08-15 |
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists Grant 6,057,345 - Breault , et al. May 2, 2 | 2000-05-02 |
Method for treating dysphagia with electrical stimulation Grant 5,987,359 - Freed , et al. November 16, 1 | 1999-11-16 |
Method and apparatus for treating oropharyngeal disorders with electrical stimulation Grant 5,891,185 - Freed , et al. April 6, 1 | 1999-04-06 |
Aromatic amino ethers as pain relieving agents Grant 5,843,942 - Breault , et al. December 1, 1 | 1998-12-01 |
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists Grant 5,834,468 - Breault , et al. November 10, 1 | 1998-11-10 |
Ortho substituted aromatic compounds useful as antagonists of the pain enhancing effects of E-type prostaglandins Grant 5,811,459 - Breault , et al. September 22, 1 | 1998-09-22 |
Method and apparatus for treating dysphagia with electrical stimulation Grant 5,725,564 - Freed , et al. March 10, 1 | 1998-03-10 |
Tricyclic heterocycles Grant 5,189,033 - Tucker February 23, 1 | 1993-02-23 |
Alkene, alkyne or cycloalkylene derivatives Grant 5,032,592 - Hughes , et al. * July 16, 1 | 1991-07-16 |
Acyanilide derivatives Grant 4,880,839 - Tucker November 14, 1 | 1989-11-14 |
Amide derivatives Grant 4,636,505 - Tucker January 13, 1 | 1987-01-13 |